: Breakthrough results from cystic fibrosis drug trials significantly expanded the company's addressable market and profit potential. Wynn Resorts (WYNN) : +95% .
Beyond individual stocks, specific industries outperformed the general market in 2017. NASDAQ:NVDA best companies to buy shares in 2017
: The board forced a massive restructuring plan in July 2017 to cut over $1 billion in costs and sell $2.5–$4 billion in assets to reduce debt. Align Technology (ALGN) : +131% . : Breakthrough results from cystic fibrosis drug trials
These large-cap companies led the broader market with significant double- and triple-digit gains. : +132% . NASDAQ:NVDA : The board forced a massive restructuring
: Record plane deliveries and a massive new stock buyback program made it the best-performing stock on the Dow Jones Industrial Average . Key Market Sector Leaders
The following report summarizes the top-performing shares and market sectors for the 2017 calendar year, a period where the rose by 19.4% . Top 5 S&P 500 Performers of 2017